🍯 Why this longevity stock is down 99%

Welcome, humans. This is Ambrosia Path, the free daily newsletter that gets you smarter about living longer 🤝

Daily Longevity Headlines

• A Texas woman is the oldest living woman in the US at 114 👵

• Naval’s longevity interview at Vitalia can now be viewed online 🎥 

• Researchers found epigenetic clocks can predict mortality and other health outcomes 🕒

• Longevity startup, Yuva Bio raised $7.5m and teamed up with BosleyMD to slow age-related hair loss 🦰

• University of Wisconsin Madison researchers found a way to 3D print human brain tissue in a ‘turning point’ for regenerative medicine 🧠

This longevity stock is down 99% 📉

UNITY Biotechnology was once the poster child of the longevity industry.

• They raised $222 million in venture capital

• Investors included Peter Thiel (co-founder PayPal, Palantir Technologies and the first outside investor in Facebook) and Jeff Bezos (Amazon founder)

• UNITY went public as $UBX in 2018, raising an additional $85 million and hitting a market cap of $700 million

Now look at them:

The stock is down 99% and market cap is now sitting at just $31m.

A far cry from even the amount raised.

What caused this?

UNITY’s goal is to develop therapeutics to slow, halt, or reverse diseases of aging.

Their scientists say aging and many aging-related diseases are caused by the buildup of old cells “senescent cells” and made this the core focus of their research.

These cells are cells that stop dividing and start to build up in the body, releasing harmful proteins that can damage surrounding tissues.

In August 2020, one of their potential therapeutics called UBX0101 failed in testing.

Will they recover?

They’re still pursuing the same approach of eliminating or modulating senescent cells but they’ve restructured around a different treatment UBX1325.

UBX1325 must prove it’s not only more effective but also superior to competitors to succeed. It’s a tall order.

Wall street analysts are bullish on the stock with two analysts giving it a ‘Strong buy’ recommendation and one giving it a ‘Buy’ recommendation in the last 90 days.

Only time will tell.

Longevity Meme of the Day

That’s it for longevity news today folks! Have a fantastic day!

Hot Tip: If this email landed in your promotions folder, move it to primary to make sure you see the next edition!

Disclaimer: This information does not constitute health advice or a recommendation and should not be considered as such